Urban Ekelund - Oasmia Pharmaceutical IR Mang
| OASMYDelisted Stock | USD 0.06 0.00 0.00% |
Insider
Urban Ekelund is IR Mang of Oasmia Pharmaceutical AB
| Phone | 46 18 50 54 40 |
| Web | https://www.vivesto.com |
Oasmia Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of (0.0875) % which means that it has lost $0.0875 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2542) %, meaning that it generated substantial loss on money invested by shareholders. Oasmia Pharmaceutical's management efficiency ratios could be used to measure how well Oasmia Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Daniel Ryweck | Silo Pharma | 59 | |
| Scott Sperling | Agiliti | 63 | |
| David Anbari | Agiliti | 56 | |
| Michael Allison | Burlington Stores | 66 | |
| Jyothi Rao | JJill Inc | N/A | |
| John Workman | Agiliti | 69 | |
| Deanna Steele | JJill Inc | 49 | |
| Dennis Hodgson | Burlington Stores | N/A | |
| Darren Friedman | Agiliti | 52 | |
| Megan Preiner | Agiliti | 37 | |
| Thomas Boehning | Agiliti | 58 | |
| Roger CPA | NetSol Technologies | 59 | |
| Michael Love | Boot Barn Holdings | 63 | |
| Joshua Nelson | Agiliti | 48 | |
| Kyle Polischuk | JJill Inc | 52 | |
| Derrick Johnson | Agiliti | 53 | |
| Danielle McCoy | Steven Madden | N/A | |
| Michael Bell | Agiliti | 65 | |
| BooAli FCA | NetSol Technologies | 49 | |
| Salim Ghauri | NetSol Technologies | 68 | |
| John Hazen | Boot Barn Holdings | 48 | |
Management Performance
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0875 |
Oasmia Pharmaceutical Leadership Team
Elected by the shareholders, the Oasmia Pharmaceutical's board of directors comprises two types of representatives: Oasmia Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Oasmia. The board's role is to monitor Oasmia Pharmaceutical's management team and ensure that shareholders' interests are well served. Oasmia Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Oasmia Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kai Wilkinson, Chief Officer | ||
| Urban Ekelund, IR Mang | ||
| Henrik Rnnberg, Chief Health | ||
| John Cosby, Head Affairs | ||
| Robert Maiorana, Head CFO | ||
| Dzianis Babrou, Head Devel | ||
| Christer MD, Acting Officer | ||
| Reinhard Koenig, Chief Officer | ||
| Johanna Rostin, Head Affairs | ||
| Maria Hagberg, Head Affairs |
Oasmia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Oasmia Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0875 | ||||
| Current Valuation | 6.58 M | ||||
| Shares Outstanding | 179.35 M | ||||
| Number Of Shares Shorted | 20.72 K | ||||
| Price To Book | 0.68 X | ||||
| Price To Sales | 31.16 X | ||||
| Revenue | 26.19 M | ||||
| Gross Profit | (15.25 M) | ||||
| EBITDA | (97.54 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Oasmia Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Oasmia Pharmaceutical's short interest history, or implied volatility extrapolated from Oasmia Pharmaceutical options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Oasmia Pink Sheet
If you are still planning to invest in Oasmia Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oasmia Pharmaceutical's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |